Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.

J Neurol · 2025 · PMC12134006 · PMID 40461909

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, patients receiving corticosteroids showed a trend toward fewer monthly headache days (MHD) and monthly migraine days (MMD), with a statistically significant reduction observed at 6 months.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.